Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices 29389

policy is contained in the Federal

Register, Vol. 60, No. 179, pages 47947–

47951, dated Friday, September 15,

1995.

Application Submission and Deadline

A. Preapplication Letters of Intent

Although not a prerequisite of

application, a non-binding letter of

intent-to-apply is requested from

potential applicants. On or before July 5,

1996, the letter should be submitted to

Kimberly P. Boyd, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 300, Atlanta GA 30305. The letter

should identify the announcement

number and the name of the

investigator. The letter does not

influence review or funding decisions,

but will enable CDC to plan the review

more efficiently, and will ensure that

each applicant receives timely and

relevant information prior to application

submission.

B. Applications

The original and two copies of the

application PHS 5161–1 (OMB Number

0937–0189) must be submitted on or

before August 5, 1996, to Mr. Van

Malone, Grants Management Officer,

Attention: Kimberly Boyd, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E15, Atlanta, GA 30305.

C. Deadline

Applications shall be considered as

meeting the deadline if they are either:

(a) Received on or before the deadline

date, or

(b) Sent on or before the deadline date

and received in time for submission to

the objective review group.

(Applicants must request a legibly dated

receipt from a commercial carrier or the

U.S. Postal Service. Private metered

postmarks are not acceptable as proof of

timely mailing.)

(c) Late Applications: Applications

which do not meet the criteria in (a) or

(b) above are considered late

applications. Late applications will not

be considered in the current

competition and will be returned to the

applicant.

Where to Obtain Additional

Information

A complete program description,

information on application procedures,

an application package, and business

management technical assistance may

be obtained from Kimberly Boyd, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E15, Atlanta GA 30305,

telephone (404) 842–6592, Facsimile

(404) 842–6513, or Internet at

<KPT0@OPSPGO1.em.cdc.gov>.

Programmatic technical assistance may

be obtained from Sevgi Aral, Ph.D.,

Division of STD Prevention, Behavioral

Interventions and Research Branch

(BIRB), National Center for STD, HIV,

and TB Prevention, Centers for Disease

Control and Prevention (CDC), 1600

Clifton Road, NE., Mailstop E02,

Atlanta, GA 30333, telephone (404)

639–8259, Facsimile (404) 639–8608.

Please refer to Announcement

Number 638 ‘‘Development and

Feasibility Testing of Interventions to

Increase Health-Seeking Behaviors in,

and Health Care for, Populations at High

Risk for Gonorrhea’’ when requesting

information and submitting an

application.

You may obtain a copy of ‘‘Healthy

People 2000,’’ (Full Report, Stock No.

017–001–00474–0) or ‘‘Healthy People

2000,’’ (Summary Report, Stock No.

017–001–00473–1) referenced in the

‘‘INTRODUCTION’’ from the

Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

There may be delays in mail delivery

and difficulty in reaching the CDC

Atlanta offices during the 1996 Summer

Olympics. Therefore, CDC suggest

applicants use Internet, follow all

instructions in this announcement and

leave messages on the contact person’s

voice mail for more timely responses to

any questions.

Dated: June 4, 1996.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–14554 Filed 6–7–96; 8:45 am]

BILLING CODE 4163–18–P

[Announcement 627]

Replication of Effective HIV Behavioral

Interventions

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1996

funds for a cooperative agreement

program for replicating HIV behavioral

interventions which have been found to

be effective in intervention research

studies. This announcement supports

the development and implementation of

plans, materials, and training to

accomplish the replication of the

intervention in one site.

The CDC is committed to achieving

the health promotion and disease

prevention objectives of ‘‘Healthy

People 2000,’’ a national activity to

reduce morbidity and mortality and

improve the quality of life. This

announcement is related to the priority

area Human Immunodeficiency Virus

(HIV) Infection. (For ordering a copy of

‘‘Healthy People 2000,’’ see the section

‘‘WHERE TO OBTAIN ADDITIONAL

INFORMATION.’’)

Authority

This program is authorized under

sections 301 and 317(k), of the Public

Health Service Act [42 U.S.C. 241 and

247b], as amended.

Smoke-Free Workplace

CDC strongly encourages all

recipients to provide a smoke-free

workplace and to promote the nonuse of

all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

Applications may be submitted by

public and private, nonprofit and forprofit organizations and governments

and their agencies. Thus, universities,

colleges, research institutes, hospitals,

other public and private organizations,

State and local health departments or

their bona fide agents or

instrumentalities, federally recognized

Indian tribal governments, Indian tribes

or Indian tribal organizations, and

small, minority- and/or women- owned

businesses are eligible to apply.

Note: Organizations described in section

501(c)(4) of the Internal Revenue Code of

1986 that engage in lobbying are not eligible

to receive Federal grant/cooperative

agreement funds.

Availability of Funds

Approximately $900,000 is available

in FY 1996 to fund approximately 5

awards. It is expected that the average

award will be $200,000, ranging from

$175,000 to $225,000. It is expected that

the awards will begin on or about

September 30, 1996, and will be made

for a 12-month budget period within a

project period of 2 years. Funding

estimates may vary and are subject to

change based on availability of funds.
29390 Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices

Continuation awards within the

project period will made on the basis of

satisfactory progress and the availability

of funds.

Priority may be given to selecting a

wide range of target populations to be

addressed by funded interventions,

including those that historically have

been addressed by few such

interventions. Collection of new or

supplemental data, data entry, purchase

of furniture or computers, and rental of

facilities or equipment will not be

funded under this program.

Definitions

For the purposes of this

announcement, the following

definitions are applicable. Replication is

defined as the creation of materials and

protocols developed from researchbased, technological innovations or

effective interventions and their

dissemination to prevention programs

or from one practice site to another for

adoption. The term community-level

intervention means an approach to HIV

prevention that (1) results from a

mobilization of community members

and institutions; (2) can be expected to

reach a large proportion of the

population at risk in their daily setting;

(3) may involve outreach and facilitybased services; and (4) can be expected

to be effective at altering individual

behaviors and community norms.

Purpose

These awards will expand the present

practice of HIV behavioral risk

prevention by: (1) encouraging

collaboration between researchers and

HIV prevention programs, (2)

developing strategies for the

dissemination of effective HIV

behavioral interventions, (3) creating

plans, materials, and training for their

implementation, and (4) facilitating

experience in local and regional

dissemination of research-based

interventions to enable HIV prevention

organizations to adopt behavioral

interventions that have been shown to

be effective.

The goal of this activity is to enhance

the capacity of local HIV prevention

organizations to implement and sustain

effective and feasible behavioral

interventions by making intervention

materials and training more widely

available, and to encourage

collaboration between researchers and

HIV prevention programs. Applications

based on community-level behavioral

interventions, and innovative and

effective interventions that have not

been widely adopted are encouraged.

The replication strategies and materials

package should be generalizable to

broad behavioral risk groups or involve

a method that can be adapted or tailored

to the needs and circumstances of one

of the priority populations identified by

the applicant’s State or local community

planning group.

Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under A. (Recipient Activities), and

CDC will be responsible for the

activities listed under B. (CDC

Activities).

A. Recipient Activities

During the first year, recipients will

develop the package of materials and

protocols and find users interested in

participating in an implementation

pretest. During the second year, the

package will be refined based on users’

pretest experience and need for the

recipient’s assistance. The program

requirements for the first year of activity

are:

1. Develop a package of materials,

protocols, and guidance to enable the

adoption of the effective behavioral

intervention. The recipient will develop

the package with the involvement of

HIV prevention programs, e.g., health

departments and community-based

organizations (CBOs), within the

applicant’s own State or within close

proximity to applicant’s home city.

a. The package will be written in

language understandable to

nonresearchers and will contain:

(1) A full description of the behavioral

intervention;

(2) A list of target populations for

whom the intervention would be

appropriate;

(3) A time line of specific steps and

costs for setting up the intervention;

(4) A list of the types of agencies

needed for collaboration on the

intervention and approaches to

establishing linkages with them;

(5) A list of all necessary materials,

other resources, staff commitment

(numbers and time) and skills, and cost

breakdowns for conducting the

intervention;

(6) Protocols for implementing the

intervention and ensuring its quality

and consistency;

(7) Specific guidelines for overcoming

barriers to implementation;

(8) Methods and procedures for

evaluating process, outcome, and costeffectiveness of the intervention; and

(9) A bibliography of publications

based on the intervention.

b. The package should include

practical examples of implementation

from the original intervention and

should contain copies of all relevant

materials.

2. Create a strategy to publicize and

market the package.

a. During the first year, the recipient

will:

(1) Compile a list of HIV prevention

agencies in the recipient’s State or

within close proximity to the recipient’s

city, which target populations for whom

the intervention is appropriate; (For this

announcement, such agencies will be

referred to as the intended users.)

(2) Select ways to inform intended

users about the availability of the

package. This strategy will be used to

identify intended users who are

interested in implementing the package

with the technical assistance of the

recipient.

b. At the end of the 2-year project, the

final package will be submitted to CDC

for further distribution.

c. The recipient may also continue to

distribute the package.

3. Develop a plan to assist the

implementation of the package. In order

to refine the package developed in year

1:

a. The recipient will develop a plan

to assist the adoption and

implementation of the behavioral

intervention by selected user(s) during

year 2.

b. The plan will include:

(1) Procedures for collecting process

data, e.g., on unforeseen barriers to

implementation, solutions to barriers,

and cost containment; and

(2) Hands-on guidance and direct

technical assistance with other

intervention components.

4. Establish a plan to evaluate the

implementation of the replication

package. The recipient will establish a

plan to evaluate the implementation of

the behavioral intervention. Such

evaluation data may:

a. Be qualitative or quantitative; and

b. Include an assessment of the

fidelity of the implementation to the

methods and protocols presented in the

package; but

c. Not include data on outcomes of

the behavioral intervention.

5. Select and confirm interested users

to adopt the package for year 2. By the

end of the year 1, the recipient will:

a. Have publicized and marketed the

package to intended users (as defined in

Recipient Activity 2);

b. Select at least one intended user

from those who have expressed interest

and confirm their willingness to

participate in year 2; and

c. Send the selected user the package

and guidance on its implementation.

(1) Limited funds may be available to

support implementation of the
Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices 29391

behavioral intervention; however, the

users are encouraged to find funds to

initiate and sustain the intervention or

may redirect their own resources.

Continued funding for year 2 will be

dependent on the completion of

required activities for year 1. In year 2,

the intervention will be implemented

and evaluated.

B. CDC Activities

1. Host a meeting with the successful

applicants within 60 days of the notice

of grant award.

2. Provide technical assistance in the

general operation of this HIV prevention

project.

3. Consult on the choice of users

selected to pretest the replication

package.

4. Monitor and evaluate scientific and

operational accomplishments of this

project through frequent telephone

contact and review of technical reports

and interim data analyses.

5. Conduct site visits to assess

program progress and mutually solve

problems, as needed.

Evaluation Criteria

Applications will be reviewed and

evaluated according to the following

criteria:

1. Behavioral Intervention (20 points

total).

a. Description and justification (8

points). The agency that originally

developed or evaluated the intervention

is the applicant or will be working in

partnership with the applicant.

Thoroughness of the description of the

intervention that will be the object of

the replication efforts. Quality of the

intervention design, components, and

methods. Appropriateness of its

theoretical basis for the target

population and intervention method.

Appropriateness of the intervention

methods for the target population.

Convincing need for the intervention’s

replication. Feasibility of

implementation by other organizations

with limited resources. Documented

permission from the original developers

of the proposed behavioral intervention

to publicize and market replication

materials and protocols generated from

the intervention.

The quality of the applicant’s

response to the item Women, Racial and

Ethnic Minorities as cited in the

‘‘APPLICATION CONTENT’’ section of

the program announcement included in

the application kit.

b. Documented effectiveness (12

points). Thoroughness of the description

of the intervention’s completed and

evaluated research. Extent of the

intervention’s effectiveness, as defined

in the Application Content. Inclusion of

publications.

2. Description of the Replication

Package (15 points).

Level of detail in the description or

outline of the proposed package,

including materials, protocols, and

guidelines. Clarity of described

intended audiences, objectives, format,

and concepts. Justification of the

appropriateness of the package’s

objectives, format, and concepts to the

intended users’ needs and capabilities.

Adequacy of input from HIV prevention

programs into the development of the

package. Adequacy of planned

materials’ review and pretesting.

Adequacy of time scheduled for

completing the proposed steps of the

package’s development.

3. Description of Plan to Identify

Users to Implement the Package (15

points).

Quality of plan to identify

appropriate, intended users and interest

them in adopting the package during

year 2 of the project. Selection of

proactive methods to identify and solicit

intended users. Adequacy of criteria and

mechanism for selecting the users for

implementing the package in year 2,

including match of the intervention’s

target population with the user’s

community planning priorities.

Recognition that the agency that

originally conducted the intervention is

excluded from implementing the

package.

4. Description of Strategy to Assist

Implementation (15 points).

Clarity of the strategy to assist

selected users in adopting and

implementing the behavioral

intervention. Understanding of barriers

to implementation and how to overcome

them. Plan to assist selected users in

implementing the intervention by using

their existing resources and staff. Plan to

help selected users find additional

funds for implementing the package, if

relevant.

5. Description of Plan to Evaluate

Implementation (15 points).

Feasibility and appropriateness of the

plan to evaluate the selected user’s

implementation of the intervention as

specified in the replication package.

Thorough and realistic selection of

intervention components to evaluate.

6. Demonstrated Capacity (20 points).

Overall ability of the applicant to

perform the proposed activities as

reflected in their staff’s and consultant’s

qualifications, experience with material

development and dissemination, and

demonstrated familiarity with HIV

behavioral interventions, in general, and

the intervention to be publicized, in

particular. The nature and extent of any

partnership between researchers and

HIV prevention programs. Adequacy of

existing support staff, equipment, and

facilities.

7. Budget (Not scored).

Extent to which the budget is

reasonable, itemized, clearly justified,

and consistent with the intended use of

the funds.

Executive Order 12372 Review

Applications are subject to

Intergovernmental Review of Federal

Programs as governed by Executive

Order (E.O.) 12372. E.O. 12372 sets up

a system for State and local government

review of proposed Federal assistance

applications. Applicants (other than

federally recognized Indian tribal

governments) should contact their State

Single Point of Contact (SPOC) as early

as possible to alert them to the

prospective applications and receive

any necessary instructions on the State

process. For proposed projects serving

more than one State, the applicant is

advised to contact the SPOC for each

affected State. A current list of SPOCs

is included in the application kit. If

SPOCs have any State process

recommendations on applications

submitted to CDC, they should send

them to Van Malone, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E15, Atlanta, GA 30305, no

later than 30 days after the application

deadline (the appropriation for this

financial assistance program was

received late in the fiscal year and

would not allow for an application

receipt date which would accommodate

the 60-day State recommendation

process period). The granting agency

does not guarantee to ‘‘accommodate or

explain’’ for State process

recommendations it receives after that

date.

Indian tribes are strongly encouraged

to request tribal government review of

the proposed application. If tribal

governments have any tribal process

recommendations on applications

submitted to the CDC, they should

forward them to Van Malone, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E15, Atlanta, GA 30305. This

should be done no later than 30 days

after the application deadline date. The

granting agency does not guarantee to

‘‘accommodate or explain’’ for tribal
29392 Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices

process recommendations it receives

after that date.

Public Health System Reporting

Requirements

This program is subject to the Public

Health System Reporting Requirements.

Under these requirements, all

community-based nongovernmental

applicants must prepare and submit the

items identified below to the head of the

appropriate State and/or local health

agency(s) in the program area(s) that

may be impacted by the proposed

project no later than the receipt date of

the Federal application. The appropriate

State and/or local health agency is

determined by the applicant. The

following information must be

provided:

A. A copy of the face page of the

application (SF 424).

B. A summary of the project that

should be titled ‘‘Public Health System

Impact Statement’’ (PHSIS), not exceed

one page, and include the following:

1. A description of the population to

be served;

2. A summary of the services to be

provided; and

3. A description of the coordination

plans with the appropriate State and/or

local health agencies.

If the State and/or local health official

should desire a copy of the entire

application, it may be obtained from the

Single Point of Contact (SPOC) or

directly from the applicant.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance number is 93.941.

Other Requirements

Human Subjects

If the proposed project involves

research on human subjects, the

applicant must comply with the

Department of Health and Human

Services Regulations, 45 CFR Part 46,

regarding the protection of human

subjects. Assurance must be provided to

demonstrate that the project will be

subject to initial and continuing review

by appropriate institutional review

committees. In addition to other

applicable committees, Indian Health

Service (IHS) institutional review

committees also must review the project

if any component of IHS will be

involved or will support the research. If

any American Indian community is

involved, its tribal government must

also approve that portion of the project

applicable to it. The applicant will be

responsible for providing assurance in

accordance with the appropriate

guidelines and form provided in the

application kit.

Women, Racial and Ethnic Minorities

It is the policy of the Centers for

Disease Control and Prevention (CDC)

and the Agency for Toxic Substances

and Disease Registry (ATSDR) to ensure

that individuals of both sexes and the

various racial and ethnic groups will be

included in CDC/ATSDR-supported

research projects involving human

subjects, whenever feasible and

appropriate. Racial and ethnic groups

are those defined in OMB Directive No.

15 and include American Indian,

Alaskan Native, Asian, Pacific Islander,

Black and Hispanic. Applicants shall

ensure that racial and ethnic minority

populations are appropriately

represented in applications for research

involving human subjects. Where clear

and compelling rationale exist that

inclusion is inappropriate or not

feasible, this situation must be

explained as part of the application.

This policy does not apply to research

studies when the investigator cannot

control the race, ethnicity and/or sex of

subjects.

Further guidance to this policy is

contained in the Federal Register, Vol.

60, No. 179, pages 47947–47951, and

dated Friday, September 15, 1995.

HIV/AIDS Requirements

Recipients must comply with the

document entitled Content of AIDSRelated Written Materials, Pictorials,

Audiovisuals, Questionnaires, Survey

Instruments, and Educational Sessions

(June 1992) (a copy is in the application

kit). To meet the requirements for a

program review panel, recipients are

encouraged to use an existing program

review panel, such as the one created by

the State health department’s HIV/AIDS

prevention program. If the recipient

forms its own program review panel, at

least one member must be an employee

(or designated representative) of a State

or local health department. The names

of the review panel members must be

listed on the Assurance of Compliance

for CDC 0.1113, which is also included

in the application kit. The recipient

must submit the program review panel’s

report that indicates all materials have

been reviewed and approved.

Application Submission and Deadlines

1. Preapplication Letter of Intent

A non-binding letter of intent-toapply is required from potential

applicants. An original and two copies

of the letter should be submitted to the

Grants Management Branch, CDC (see

‘‘Applications’’ in the following

paragraph). It should be postmarked no

later than July 15, 1996. The letter

should identify the announcement

number, name of principal investigator,

and specify the activity(ies) to be

addressed by the proposed project. The

letter of intent does not influence

review or funding decisions, but it will

enable CDC to plan the review more

efficiently, and will ensure that each

applicant receives timely and relevant

information prior to application

submission.

2. Applications

An original and two copies of the

application PHS Form 5161–1 (OMB

Number 0937–0189) must be submitted

to Van Malone, Grants Management

Officer, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 300, Mailstop E–15, Atlanta, GA

30305, on or before August 15, 1996.

3. Deadlines

A. Applications shall be considered as

meeting the deadline if they are either:

(1.) Received on or before the

deadline date; or

(2.) Sent on or before the deadline

date and received in time for

submission to the objective review

group. (Applicants must request a

legibly dated U.S.Postal Service

postmark or obtain a legibly dated

receipt from a commercial carrier or the

U.S. Postal Service. Private metered

postmarks shall not be acceptable as

proof of timely mailing.)

B. Applications that do not meet the

criteria in 3.A.(1.) or 3.A.(2.) above are

considered late applications. Late

applications will not be considered in

the current competition and will be

returned to the applicant.

Where to Obtain Additional

Information

To receive additional information call

(404) 332–4561. You will be asked to

leave your name, address, and phone

number and will need to refer to

Announcement 627. You will receive a

complete program description,

information on application procedures,

and application forms.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from

Adrienne Brown, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 300, Mailstop E–15, Atlanta, GA

30305, telephone (404) 842–6634, email:
Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices 29393

<asm1@opspgo1.em.cdc.gov>.

Programmatic technical assistance may

be obtained from Robert Kohmescher,

Division of HIV/AIDS Prevention,

National Center for HIV/STD/TB

Prevention, Centers for Disease Control

and Prevention (CDC), 1600 Clifton

Road, NE., Mailstop E–44, Atlanta, GA

30333, telephone (404) 639–8302, email:

<rnk1@cidhiv2.em.cdc.gov>.

Please refer to Announcement 627

when requesting information and

submitting an application.

Potential applicants may obtain a

copy of ‘‘Healthy People 2000,’’ (Full

Report, Stock No. 017–001–00474–0) or

‘‘Healthy People 2000,’’ (Summary

Report, Stock No. 017–001–00473–1)

referenced in the ‘‘INTRODUCTION,’’

through the Superintendent of

Documents, Government Printing

Office, Washington, DC 20402–9325,

telephone (202) 512–1800.

Internet Home Page

The announcement will be available

on one of two Internet sites on the

publication date: CDC’s home page at

<http://www.cdc.gov>, or at the

Government Printing Office home page

(including free access to the Federal

Register) at <http://

www.access.gpo.gov>.

There may be delays in mail delivery

and difficulty in reaching the CDC

Atlanta offices during the 1996 Summer

Olympics. Therefore, CDC suggests

applicants use Internet, follow all

instructions in this announcement and

leave messages on the contact person’s

voice mail for more timely responses to

questions.

Dated: June 4, 1996.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 96–14550 Filed 6–07–96; 8:45 am]

BILLING CODE 4163–18–P

[Announcement 626]

Follow-up or Secondary Analysis of

HIV Behavioral Intervention Research

Studies

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1996

funds for a grant program for conducting

follow-up or secondary analysis of data

from HIV behavioral intervention

research studies. This announcement

provides funds for two types of

activities:

Activity 1 Follow-up or secondary

analysis of outcome, process, or

economic data from existing HIV

behavioral intervention data sets, and;

Activity 2 Secondary analysis of

existing behavioral intervention data

with methodological implications for

how to conduct, analyze, or interpret

research findings from behavioral

intervention studies.

The CDC is committed to achieving

the health promotion and disease

prevention objectives of ‘‘Healthy

People 2000,’’ a national activity to

reduce morbidity and mortality and

improve the quality of life. This

announcement is related to the priority

area of Human Immunodeficiency Virus

(HIV) Infection. (For ordering a copy of

‘‘Healthy People 2000,’’ see the section

‘‘WHERE TO OBTAIN ADDITIONAL

INFORMATION.’’)

Authority

This program is authorized under

sections 301 and 317(k), of the Public

Health Service Act [42 U.S.C. 241 and

247b], as amended.

Smoke-Free Workplace

CDC strongly encourages all

recipients to provide a smoke-free

workplace and to promote the nonuse of

all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

Applications may be submitted by

public and private, nonprofit and forprofit organizations and governments

and their agencies. Thus, universities,

colleges, research institutes, hospitals,

other public and private organizations,

State and local health departments or

their bona fide agents or

instrumentalities, federally recognized

Indian tribal governments, Indian tribes

or Indian tribal organizations, and

small, minority- and/or women-owned

businesses are eligible to apply.

Eligible applicants must have access

to data sets of outcome, process, or

economic data collected during efficacy

or effectiveness studies of HIV

behavioral interventions in the United

States.

Applicants may submit applications

for both Activity 1 (follow-up or

secondary analysis) and Activity 2

(analysis with methodological

implications) but must submit them as

separate applications. Applications

must state the activity type of the

proposal in the application’s title.

Note: Organizations described in section

501(c)(4) of the Internal Revenue Code of

1986 that engage in lobbying are not eligible

to receive Federal grant/cooperative

agreement funds.

Availability of Funds

Approximately $600,000 is available

in FY 1996 to fund a total of

approximately six awards under

Activities 1 and 2. It is expected that the

average award will range from $80,000

to $120,000, depending on the number

of analyses proposed. Awards are

expected to begin on or about

September 30, 1996, and will be made

for a 12-month budget period within a

project period of one year. Funding

estimates may vary and are subject to

change based on availability of funds.

Grant funds are to be applied to

analyses of existing behavioral

intervention data and cannot be used for

the collection of new or supplemental

data, secondary analyses of behavioral

survey data, data entry, purchase of

furniture, software, computers, rental of

facilities, equipment or support of

interventions.

Purpose

These awards will expand the

knowledge of HIV behavioral risk

prevention by conducting further

analyses of data sets from completed

research on HIV behavioral

interventions. Proposals are sought for

the following activities:

Activity 1 Follow-up or secondary

analysis of existing data sets collected

during efficacy or effectiveness trials of

theory-based HIV behavioral

interventions.

Activity 2 Secondary analysis of

existing behavioral intervention data

with methodological implications for

how to conduct, analyze, or interpret

research findings from behavioral

intervention studies. Examples of

analyses include methods to assess the

reliability or validity of behavioral

measures, implementation and

evaluation of intervention methods, the

relationship between behavioral and

biological outcome measures (including

STD and HIV transmission),

comparisons of data collection or

sampling methods, methods to identify

social networks, methods to determine

cost-benefit or cost-effectiveness, and

the use of behavioral intervention data

to model transmission trends.

These awards also have the goal of

obtaining information on diverse

populations, on populations for whom

there is little information on

intervention effectiveness, on

interventions conducted in geographic

areas or venue types on which there is

little intervention information, and on